chloramphenicol has been researched along with pheniramine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Furkert, K | 1 |
2 review(s) available for chloramphenicol and pheniramine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
[Rhinologic agents. 14].
Topics: Acridines; Adrenal Cortex Hormones; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Boric Acids; Chloramphenicol; Dexamethasone; Diphenhydramine; Ephedrine; Epinephrine; Histamine H1 Antagonists; Humans; Hydrocortisone; Imidazoles; Methoxamine; Naphazoline; Nasal Decongestants; Neomycin; Nose Diseases; Oils, Volatile; Oxymetazoline; Pheniramine; Prednisolone; Prednisone; Triamcinolone; Tripelennamine | 1967 |
1 other study(ies) available for chloramphenicol and pheniramine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |